Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Respect for Patient Decision Making: Mr. Douglas's Choice of Treatment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5-0501. Case and Commentary Jan 2005 Surrogate Decision Making: Mrs. Douglas's Choice of Treatment for Her Husband Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7-0501. Case and Commentary Jan 2005 Duty to Report: An HIV Diagnosis Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9-0501. Case and Commentary Jan 2005 Gifts from Industry: The Cost of Lunch Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):96-100. doi: 10.1001/virtualmentor.2005.7.1.ccas16-0501. Case and Commentary Jan 2005 Treatment of Family Members and Significant Others: All in the Family Jennifer Reenan, MD Virtual Mentor. 2005;7(1):111-116. doi: 10.1001/virtualmentor.2005.7.1.ccas19-0501. Policy Forum Jan 2013 Evidence-Based Guidelines and Quality Measures in the Care of Older Adults Erika Ramsdale, MD and William Dale, MD, PhD This process of developing EBM-based guidelines and applying them to clinical care highlights the tension between generating unbiased knowledge based on statistical aggregation and the application of this information to individual patients. Virtual Mentor. 2013;15(1):51-55. doi: 10.1001/virtualmentor.2013.15.1.pfor1-1301. Medicine and Society Apr 2024 Mapping a Way to Displaced Persons’ Access to Quality Medicines Carly Ching, PhD and Muhammad H. Zaman, PhD Reliable supply of quality-assured medicines is hard to maintain in refugee camps in low- and middle-income countries with conflict zones. AMA J Ethics. 2024;26(4):E341-347. doi: 10.1001/amajethics.2024.341. Health Law Apr 2024 What Should Prescribers and Policy Makers Know About US Drug Importation? Nisha Quasba, MPH and Elliot Vice International medicine importation raises ethics and safety questions that should be considered when weighing affordability against risk of harm. AMA J Ethics. 2024;26(4):E295-302. doi: 10.1001/amajethics.2024.295. Medicine and Society Apr 2024 How Should We Draw on Pharmacists’ Expertise to Manage Drug Shortages in Hospitals? Michael Ganio, PharmD, MS Pharmacists can help limit the threats drug shortages pose to patients. AMA J Ethics. 2024;26(4):E327-333. doi: 10.1001/amajethics.2024.327. Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
Case and Commentary Jan 2005 Respect for Patient Decision Making: Mr. Douglas's Choice of Treatment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5-0501.
Case and Commentary Jan 2005 Surrogate Decision Making: Mrs. Douglas's Choice of Treatment for Her Husband Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7-0501.
Case and Commentary Jan 2005 Duty to Report: An HIV Diagnosis Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9-0501.
Case and Commentary Jan 2005 Gifts from Industry: The Cost of Lunch Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):96-100. doi: 10.1001/virtualmentor.2005.7.1.ccas16-0501.
Case and Commentary Jan 2005 Treatment of Family Members and Significant Others: All in the Family Jennifer Reenan, MD Virtual Mentor. 2005;7(1):111-116. doi: 10.1001/virtualmentor.2005.7.1.ccas19-0501.
Policy Forum Jan 2013 Evidence-Based Guidelines and Quality Measures in the Care of Older Adults Erika Ramsdale, MD and William Dale, MD, PhD This process of developing EBM-based guidelines and applying them to clinical care highlights the tension between generating unbiased knowledge based on statistical aggregation and the application of this information to individual patients. Virtual Mentor. 2013;15(1):51-55. doi: 10.1001/virtualmentor.2013.15.1.pfor1-1301.
Medicine and Society Apr 2024 Mapping a Way to Displaced Persons’ Access to Quality Medicines Carly Ching, PhD and Muhammad H. Zaman, PhD Reliable supply of quality-assured medicines is hard to maintain in refugee camps in low- and middle-income countries with conflict zones. AMA J Ethics. 2024;26(4):E341-347. doi: 10.1001/amajethics.2024.341.
Health Law Apr 2024 What Should Prescribers and Policy Makers Know About US Drug Importation? Nisha Quasba, MPH and Elliot Vice International medicine importation raises ethics and safety questions that should be considered when weighing affordability against risk of harm. AMA J Ethics. 2024;26(4):E295-302. doi: 10.1001/amajethics.2024.295.
Medicine and Society Apr 2024 How Should We Draw on Pharmacists’ Expertise to Manage Drug Shortages in Hospitals? Michael Ganio, PharmD, MS Pharmacists can help limit the threats drug shortages pose to patients. AMA J Ethics. 2024;26(4):E327-333. doi: 10.1001/amajethics.2024.327.
Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289.